Biomea Fusion Inc BMEA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/07/21 EDT
16.94quote price arrow down-0.14 (-0.82%)
Volume
53,700
52 week range
15.15 - 22.22

...

Loading . . .
  • Open16.87
  • Day High17.12
  • Day Low16.50
  • Prev Close17.08
  • 52 Week High22.22
  • 52 Week High Date04/16/21
  • 52 Week Low15.15
  • 52 Week Low Date04/20/21

Key Stats

  • Market Cap487.36M
  • Shares Out28.77M
  • 10 Day Average Volume0.08M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

KEY STATS

  • Open16.87
  • Day High17.12
  • Day Low16.50
  • Prev Close17.08
  • 52 Week High22.22
  • 52 Week High Date04/16/21
  • 52 Week Low15.15
  • 52 Week Low Date04/20/21
  • Market Cap487.36M
  • Shares Out28.77M
  • 10 Day Average Volume0.08M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.19
  • P/E (TTM)-91.52
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Biomea Fusion Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Biomea Fusion, Inc. is a preclinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The Company has built FUSION System discovery platform to advance a pipeline of irreversible small molecule product candidates. The Company's lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective...
Thomas Butler
Chief Executive Officer
Ramses Erdtmann
President
Heow Tan
Chief Technology Officer
Address
726 Main Street
Redwood City, CA
94063
United States